Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalumab)
产品介绍
产品性质
产品特色
应用案例
Purity:SDS-PAGE
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
Purity:SEC-HPLC
The purity of Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalumab) is 100%, determined by SEC-HPLC.
Research in vivo
Durvalumab inhibited the tumor growth of A375 on NOD.SCID mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 61.2% at 5 mpk at D22.
存储条件
-25~-15℃保存，有效期1年。
COA
已发表文献
相关产品
联系我们
